Endoscopic direct vessel closure in carotid artery injury

Padhye, Vikram; Murphy, Jae; Bassiouni, Ahmed; Valentine, Rowan; Wormald, Peter‐John

doi:10.1002/alr.21453

Cited by 20 publications

(20 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Because there is limited clinical data on endoscopic ICA injury repair in humans, several authors have developed animal models as a surrogate to assess efficacy of intraoperative repair methods . Valentine used a sheep model to compare crushed muscle with other hemostatic techniques and found muscle superior to oxidized cellulose Floseal® (Baxter, Deerfield, IL) and Chitosan gel (Surgi Shield; D. med, Seoul, Korea) .…”

Section: Complicationsmentioning

confidence: 99%

“…There was a lower rate of pseudoaneurysm formation with clipping, but carotid patency rates were superior with crushed muscle. Using the same study design, Padhye et al . later compared the Anastoclip Device with the prior mentioned methods and found decreased blood loss and time to hemostasis with good rates of ICA patency.…”

Section: Complicationsmentioning

confidence: 99%

“…recommended aneurysmal clips as an effective option for major arterial vascular injury while trying to preserve vascular patency and preservation. The use of a novel AnastoClip vessel closure system has also been shown to be effective in all cases in a sheep model, with only 1 pseudoaneurysm out of 9 cases . The use of all clip devices, however, does require some level of surgical exposure of the injury site, and may be more technically challenging to apply.…”

Section: Intraoperative Considerationsmentioning

confidence: 99%

See 2 more Smart Citations

ICAR: endoscopic skull‐base surgery

Wang

Zanation

Gardner

et al. 2019

Int Forum Allergy Rhinol

160

279

View full text Add to dashboard Cite

Background Endoscopic skull‐base surgery (ESBS) is employed in the management of diverse skull‐base pathologies. Paralleling the increased utilization of ESBS, the literature in this field has expanded rapidly. However, the rarity of these diseases, the inherent challenges of surgical studies, and the continued learning curve in ESBS have resulted in significant variability in the quality of the literature. To consolidate and critically appraise the available literature, experts in skull‐base surgery have produced the International Consensus Statement on Endoscopic Skull‐Base Surgery (ICAR:ESBS). Methods Using previously described methodology, topics spanning the breadth of ESBS were identified and assigned a literature review, evidence‐based review or evidence‐based review with recommendations format. Subsequently, each topic was written and then reviewed by skull‐base surgeons in both neurosurgery and otolaryngology. Following this iterative review process, the ICAR:ESBS document was synthesized and reviewed by all authors for consensus. Results The ICAR:ESBS document addresses the role of ESBS in primary cerebrospinal fluid (CSF) rhinorrhea, intradural tumors, benign skull‐base and orbital pathology, sinonasal malignancies, and clival lesions. Additionally, specific challenges in ESBS including endoscopic reconstruction and complication management were evaluated. Conclusion A critical review of the literature in ESBS demonstrates at least the equivalency of ESBS with alternative approaches in pathologies such as CSF rhinorrhea and pituitary adenoma as well as improved reconstructive techniques in reducing CSF leaks. Evidence‐based recommendations are limited in other pathologies and these significant knowledge gaps call upon the skull‐base community to embrace these opportunities and collaboratively address these shortcomings.

show abstract

Section: Complicationsmentioning

confidence: 99%

Section: Complicationsmentioning

confidence: 99%

Section: Intraoperative Considerationsmentioning

confidence: 99%

See 1 more Smart Citation

ICAR: endoscopic skull‐base surgery

Wang

Zanation

Gardner

et al. 2019

Int Forum Allergy Rhinol

160

279

View full text Add to dashboard Cite

show abstract

“…Endoscopic endonasal surgery (EES) for treating paranasal and ventral skull base pathology has revolutionized surgical therapy for the management of various conditions. This approach has led to decreased morbidity and mortality and improved patient outcomes secondary to various advantages of EES, such as improved visualization, avoidance of external skin incisions, and reduced postoperative pain with shorter hospital admissions . Complications of EES that can occur include cerebrospinal fluid (CSF) leak, orbital hematoma, diplopia, dural injury, and vascular injury .…”

Section: Introductionmentioning

confidence: 99%

“…This approach has led to decreased morbidity and mortality and improved patient outcomes secondary to various advantages of EES, such as improved visualization, avoidance of external skin incisions, and reduced postoperative pain with shorter hospital admissions. [1][2][3] Complications of EES that can occur include cerebrospinal fluid (CSF) leak, orbital hematoma, diplopia, dural injury, and vascular injury. 1,[4][5][6] Although by many accounts it is a rare phenomenon, the most feared and devastating complication during EES is injury of the internal carotid artery (ICA).…”

Section: Introductionmentioning

confidence: 99%

Internal carotid artery injury in endoscopic endonasal surgery: A systematic review

et al. 2015

View full text Add to dashboard Cite

show abstract

Short Peptide Nanofiber Biomaterials Ameliorate Local Hemostatic Capacity of Surgical Materials and Intraoperative Hemostatic Applications in Clinics

et al. 2023

View full text Add to dashboard Cite

Short designer self‐assembling peptide (dSAP) biomaterials are a new addition to the hemostat group. It may provide a diverse and robust toolbox for surgeons to integrate wound microenvironment with much safer and stronger hemostatic capacity than conventional materials and hemostatic agents. Especially in noncompressible torso hemorrhage (NCTH), diffuse mucosal surface bleeding, and internal medical bleeding (IMB), with respect to the optimal hemostatic formulation, dSAP biomaterials are the ingenious nanofiber alternatives to make bioactive neural scaffold, nasal packing, large mucosal surface coverage in gastrointestinal surgery (esophagus, gastric lesion, duodenum, and lower digestive tract), epicardiac cell‐delivery carrier, transparent matrix barrier, and so on. Herein, in multiple surgical specialties, dSAP‐biomaterial‐based nano‐hemostats achieve safe, effective, and immediate hemostasis, facile wound healing, and potentially reduce the risks in delayed bleeding, rebleeding, post‐operative bleeding, or related complications. The biosafety in vivo, bleeding indications, tissue‐sealing quality, surgical feasibility, and local usability are addressed comprehensively and sequentially and pursued to develop useful surgical techniques with better hemostatic performance. Here, the state of the art and all‐round advancements of nano‐hemostatic approaches in surgery are provided. Relevant critical insights will inspire exciting investigations on peptide nanotechnology, next‐generation biomaterials, and better promising prospects in clinics.

show abstract

Endoscopic direct vessel closure in carotid artery injury

Cited by 20 publications

References 14 publications

ICAR: endoscopic skull‐base surgery

ICAR: endoscopic skull‐base surgery

Internal carotid artery injury in endoscopic endonasal surgery: A systematic review

Short Peptide Nanofiber Biomaterials Ameliorate Local Hemostatic Capacity of Surgical Materials and Intraoperative Hemostatic Applications in Clinics

Contact Info

Product

Resources

About